APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ovulation Induction

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ovulation Induction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174021310330 December 2025197 pages

Choose your research edition.

Industry ResearchOvulation Induction Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Ovulation Induction Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Ovulation Induction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ovulation Induction Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Ovulation Induction Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Ovulation Induction market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ovulation Induction include Takeda, Sanofi, Merck & Co. Inc, AbbVie, AstraZeneca, Unichem Laboratories, Teva Pharmaceuticals USA, Inc, TerSera Therapeutics and Techwell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Ovulation Induction market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ovulation Induction and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ovulation Induction revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ovulation Induction market size, projected growth trends, production technologies, key applications, and end-use industries.

Ovulation Induction Segment by Company

Takeda

Sanofi

Merck & Co. Inc

AbbVie

AstraZeneca

Unichem Laboratories

Teva Pharmaceuticals USA, Inc

TerSera Therapeutics

Techwell

Sun Pharmaceutical

Pharmascience Inc

Par pharmaceutical inc

Pacific Pharmaceuticals

LIVZON

Ipsen

IBSA

IBM Micromedex

Gedeon Richter

Fresenius Kabi

Ferring

Endo

EMD Serono Inc

Emcure Pharmaceuticals Ltd.

Cosette Pharmaceuticals, Inc

Bristol Myers Squibb

Ovulation Induction Segment by Type

Follicle Stimulating Hormone

Clomiphene Citrate

Human Menopausal Gonadotropin

Human Chorionic Gonadotropin

Others

Ovulation Induction Segment by Application

Clinic

Hospital

Medical Institution

Ovulation Induction Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovulation Induction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ovulation Induction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovulation Induction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ovulation Induction in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ovulation Induction industry.

Chapter 3: Detailed analysis of Ovulation Induction companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ovulation Inductionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ovulation Induction Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Follicle Stimulating Hormone Table 3. Key Players of Clomiphene Citrate Table 4. Key Players of Human Menopausal Gonadotropin Table 3. Key Players of Human Chorionic Gonadotropin Table 4. Key Players of Others Table 5. Global Ovulation Induction Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Clinic Table 7. Key Players of Hospital Table 8. Key Players of Medical Institution Table 9. Global Ovulation Induction Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Ovulation Induction Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Ovulation Induction Market Share by Region (2021-2026) Table 12. Global Ovulation Induction Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Ovulation Induction Market Share by Region (2027-2032) Table 14. Ovulation Induction Industry Trends Table 15. Ovulation Induction Industry Drivers Table 16. Ovulation Induction Industry Opportunities and Challenges Table 17. Ovulation Induction Industry Restraints Table 18. Global Ovulation Induction Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Ovulation Induction Revenue Market Share by Company (2021-2026) Table 20. Global Ovulation Induction Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Ovulation Induction Key Company Head Office and Area Served Table 22. Global Ovulation Induction Company, Product Type & Application Table 23. Global Ovulation Induction Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Ovulation Induction by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Ovulation Induction Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Ovulation Induction Revenue Market Share by Type (2021-2026) Table 30. Global Ovulation Induction Revenue Market Share by Type (2027-2032) Table 31. Global Ovulation Induction Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Ovulation Induction Revenue Market Share by Application (2021-2026) Table 35. Global Ovulation Induction Revenue Market Share by Application (2027-2032) Table 36. Takeda Company Information Table 37. Takeda Business Overview Table 38. Takeda Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Takeda Ovulation Induction Product Portfolio Table 40. Takeda Recent Development Table 41. Sanofi Company Information Table 42. Sanofi Business Overview Table 43. Sanofi Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sanofi Ovulation Induction Product Portfolio Table 45. Sanofi Recent Development Table 46. Merck & Co. Inc Company Information Table 47. Merck & Co. Inc Business Overview Table 48. Merck & Co. Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Merck & Co. Inc Ovulation Induction Product Portfolio Table 50. Merck & Co. Inc Recent Development Table 51. AbbVie Company Information Table 52. AbbVie Business Overview Table 53. AbbVie Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AbbVie Ovulation Induction Product Portfolio Table 55. AbbVie Recent Development Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AstraZeneca Ovulation Induction Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Unichem Laboratories Company Information Table 62. Unichem Laboratories Business Overview Table 63. Unichem Laboratories Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Unichem Laboratories Ovulation Induction Product Portfolio Table 65. Unichem Laboratories Recent Development Table 66. Teva Pharmaceuticals USA, Inc Company Information Table 67. Teva Pharmaceuticals USA, Inc Business Overview Table 68. Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio Table 70. Teva Pharmaceuticals USA, Inc Recent Development Table 71. TerSera Therapeutics Company Information Table 72. TerSera Therapeutics Business Overview Table 73. TerSera Therapeutics Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. TerSera Therapeutics Ovulation Induction Product Portfolio Table 75. TerSera Therapeutics Recent Development Table 76. Techwell Company Information Table 77. Techwell Business Overview Table 78. Techwell Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Techwell Ovulation Induction Product Portfolio Table 80. Techwell Recent Development Table 81. Sun Pharmaceutical Company Information Table 82. Sun Pharmaceutical Business Overview Table 83. Sun Pharmaceutical Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sun Pharmaceutical Ovulation Induction Product Portfolio Table 85. Sun Pharmaceutical Recent Development Table 86. Pharmascience Inc Company Information Table 87. Pharmascience Inc Business Overview Table 88. Pharmascience Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Pharmascience Inc Ovulation Induction Product Portfolio Table 90. Pharmascience Inc Recent Development Table 91. Par pharmaceutical inc Company Information Table 92. Par pharmaceutical inc Business Overview Table 93. Par pharmaceutical inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Par pharmaceutical inc Ovulation Induction Product Portfolio Table 95. Par pharmaceutical inc Recent Development Table 96. Pacific Pharmaceuticals Company Information Table 97. Pacific Pharmaceuticals Business Overview Table 98. Pacific Pharmaceuticals Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Pacific Pharmaceuticals Ovulation Induction Product Portfolio Table 100. Pacific Pharmaceuticals Recent Development Table 101. LIVZON Company Information Table 102. LIVZON Business Overview Table 103. LIVZON Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. LIVZON Ovulation Induction Product Portfolio Table 105. LIVZON Recent Development Table 106. Ipsen Company Information Table 107. Ipsen Business Overview Table 108. Ipsen Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Ipsen Ovulation Induction Product Portfolio Table 110. Ipsen Recent Development Table 111. IBSA Company Information Table 112. IBSA Business Overview Table 113. IBSA Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. IBSA Ovulation Induction Product Portfolio Table 115. IBSA Recent Development Table 116. IBM Micromedex Company Information Table 117. IBM Micromedex Business Overview Table 118. IBM Micromedex Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. IBM Micromedex Ovulation Induction Product Portfolio Table 120. IBM Micromedex Recent Development Table 121. Gedeon Richter Company Information Table 122. Gedeon Richter Business Overview Table 123. Gedeon Richter Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Gedeon Richter Ovulation Induction Product Portfolio Table 125. Gedeon Richter Recent Development Table 126. Fresenius Kabi Company Information Table 127. Fresenius Kabi Business Overview Table 128. Fresenius Kabi Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Fresenius Kabi Ovulation Induction Product Portfolio Table 130. Fresenius Kabi Recent Development Table 131. Ferring Company Information Table 132. Ferring Business Overview Table 133. Ferring Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Ferring Ovulation Induction Product Portfolio Table 135. Ferring Recent Development Table 136. Endo Company Information Table 137. Endo Business Overview Table 138. Endo Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Endo Ovulation Induction Product Portfolio Table 140. Endo Recent Development Table 141. EMD Serono Inc Company Information Table 142. EMD Serono Inc Business Overview Table 143. EMD Serono Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. EMD Serono Inc Ovulation Induction Product Portfolio Table 145. EMD Serono Inc Recent Development Table 146. Emcure Pharmaceuticals Ltd. Company Information Table 147. Emcure Pharmaceuticals Ltd. Business Overview Table 148. Emcure Pharmaceuticals Ltd. Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio Table 150. Emcure Pharmaceuticals Ltd. Recent Development Table 151. Cosette Pharmaceuticals, Inc Company Information Table 152. Cosette Pharmaceuticals, Inc Business Overview Table 153. Cosette Pharmaceuticals, Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio Table 155. Cosette Pharmaceuticals, Inc Recent Development Table 156. Bristol Myers Squibb Company Information Table 157. Bristol Myers Squibb Business Overview Table 158. Bristol Myers Squibb Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026) Table 159. Bristol Myers Squibb Ovulation Induction Product Portfolio Table 160. Bristol Myers Squibb Recent Development Table 161. North America Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 162. North America Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 163. North America Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 164. North America Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 165. North America Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Ovulation Induction Market Size by Country (2021-2026) Table 167. North America Ovulation Induction Market Size by Country (2027-2032) Table 168. Europe Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 169. Europe Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 170. Europe Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 171. Europe Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 172. Europe Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Ovulation Induction Market Size by Country (2021-2026) Table 174. Europe Ovulation Induction Market Size by Country (2027-2032) Table 175. China Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 176. China Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 177. China Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 178. China Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 179. Asia Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 180. Asia Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 181. Asia Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 182. Asia Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 183. Asia Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Ovulation Induction Market Size by Country (2021-2026) Table 185. Asia Ovulation Induction Market Size by Country (2027-2032) Table 186. South America, Middle East & Africa Ovulation Induction Market Size by Type (2021-2026) & (US$ Million) Table 187. South America, Middle East & Africa Ovulation Induction Market Size by Type (2027-2032) & (US$ Million) Table 188. South America, Middle East & Africa Ovulation Induction Market Size by Application (2021-2026) & (US$ Million) Table 189. South America, Middle East & Africa Ovulation Induction Market Size by Application (2027-2032) & (US$ Million) Table 190. South America, Middle East & Africa Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. South America, Middle East & Africa Ovulation Induction Market Size by Country (2021-2026) Table 192. South America, Middle East & Africa Ovulation Induction Market Size by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Ovulation Induction Product Image Figure 2. Global Ovulation Induction Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Ovulation Induction Market Share by Type: 2025 VS 2032 Figure 4. Follicle Stimulating Hormone Image Figure 5. Clomiphene Citrate Image Figure 6. Human Menopausal Gonadotropin Image Figure 7. Human Chorionic Gonadotropin Image Figure 8. Others Image Figure 9. Global Ovulation Induction Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Ovulation Induction Market Share by Application: 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Medical Institution Image Figure 14. Global Ovulation Induction Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 16. Global Ovulation Induction Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Ovulation Induction Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Ovulation Induction Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Ovulation Induction Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Ovulation Induction Revenue Market Share by Type (2021-2032) Figure 23. Global Ovulation Induction Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ovulation Induction Revenue Market Share by Application (2021-2032) Figure 25. North America Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 26. North America Ovulation Induction Market Share by Type (2021-2032) Figure 27. North America Ovulation Induction Market Share by Application (2021-2032) Figure 28. North America Ovulation Induction Market Share by Country (2021-2032) Figure 29. United States Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 30. Canada Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 32. Europe Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 33. Europe Ovulation Induction Market Share by Type (2021-2032) Figure 34. Europe Ovulation Induction Market Share by Application (2021-2032) Figure 35. Europe Ovulation Induction Market Share by Country (2021-2032) Figure 36. Germany Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 37. France Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 39. Italy Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 40. Russia Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 42. China Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 43. China Ovulation Induction Market Share by Type (2021-2032) Figure 44. China Ovulation Induction Market Share by Application (2021-2032) Figure 45. Asia Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 46. Asia Ovulation Induction Market Share by Type (2021-2032) Figure 47. Asia Ovulation Induction Market Share by Application (2021-2032) Figure 48. Asia Ovulation Induction Market Share by Country (2021-2032) Figure 49. Japan Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 53. India Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 54. Australia Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Ovulation Induction Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Ovulation Induction Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Ovulation Induction Market Share by Country (2021-2032) Figure 59. Brazil Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 64. UAE Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 66. Chile Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Follicle Stimulating Hormone
  • Clomiphene Citrate
  • Human Menopausal Gonadotropin
  • Human Chorionic Gonadotropin
  • Others
Applications
  • Clinic
  • Hospital
  • Medical Institution
Companies covered
  • Takeda
  • Sanofi
  • Merck & Co. Inc
  • AbbVie
  • AstraZeneca
  • Unichem Laboratories
  • Teva Pharmaceuticals USA, Inc
  • TerSera Therapeutics
  • Techwell
  • Sun Pharmaceutical
  • Pharmascience Inc
  • Par pharmaceutical inc
  • Pacific Pharmaceuticals
  • LIVZON
  • Ipsen
  • IBSA
  • IBM Micromedex
  • Gedeon Richter
  • Fresenius Kabi
  • Ferring
  • Endo
  • EMD Serono Inc
  • Emcure Pharmaceuticals Ltd.
  • Cosette Pharmaceuticals, Inc
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Ovulation Induction Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Follicle Stimulating Hormone
  5. 1.2.3 Clomiphene Citrate
  6. 1.2.4 Human Menopausal Gonadotropin
  7. 1.2.5 Human Chorionic Gonadotropin
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Ovulation Induction Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Medical Institution
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Ovulation Induction Growth Trends by Region
  16. 1.5.1 Global Ovulation Induction Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Ovulation Induction Market Size by Region (2021-2026)
  18. 1.5.3 Ovulation Induction Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Ovulation Induction Market Dynamics
  1. 2.1 Ovulation Induction Industry Trends
  2. 2.2 Ovulation Induction Industry Drivers
  3. 2.3 Ovulation Induction Industry Opportunities and Challenges
  4. 2.4 Ovulation Induction Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Ovulation Induction Revenue by Company (2021-2026)
  2. 3.2 Global Ovulation Induction Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Ovulation Induction Key Company Head office and Area Served
  4. 3.4 Global Ovulation Induction Company, Product Type & Application
  5. 3.5 Global Ovulation Induction Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Ovulation Induction Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Ovulation Induction Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Ovulation Induction Tier 1, Tier 2, and Tier 3
4 Ovulation Induction Market by Type
  1. 4.1 Global Ovulation Induction Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Ovulation Induction Market Size by Type (2021-2032)
  3. 4.3 Global Ovulation Induction Market Size Share by Type (2021-2032)
5 Ovulation Induction Market by Application
  1. 5.1 Global Ovulation Induction Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Ovulation Induction Market Size by Application (2021-2032)
  3. 5.3 Global Ovulation Induction Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Ovulation Induction Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Ovulation Induction Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck & Co. Inc
  14. 6.3.1 Merck & Co. Inc Company Information
  15. 6.3.2 Merck & Co. Inc Business Overview
  16. 6.3.3 Merck & Co. Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co. Inc Ovulation Induction Product Portfolio
  18. 6.3.5 Merck & Co. Inc Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AbbVie Ovulation Induction Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Ovulation Induction Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Unichem Laboratories
  32. 6.6.1 Unichem Laboratories Company Information
  33. 6.6.2 Unichem Laboratories Business Overview
  34. 6.6.3 Unichem Laboratories Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Unichem Laboratories Ovulation Induction Product Portfolio
  36. 6.6.5 Unichem Laboratories Recent Developments
  37. 6.7 Teva Pharmaceuticals USA, Inc
  38. 6.7.1 Teva Pharmaceuticals USA, Inc Company Information
  39. 6.7.2 Teva Pharmaceuticals USA, Inc Business Overview
  40. 6.7.3 Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio
  42. 6.7.5 Teva Pharmaceuticals USA, Inc Recent Developments
  43. 6.8 TerSera Therapeutics
  44. 6.8.1 TerSera Therapeutics Company Information
  45. 6.8.2 TerSera Therapeutics Business Overview
  46. 6.8.3 TerSera Therapeutics Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 TerSera Therapeutics Ovulation Induction Product Portfolio
  48. 6.8.5 TerSera Therapeutics Recent Developments
  49. 6.9 Techwell
  50. 6.9.1 Techwell Company Information
  51. 6.9.2 Techwell Business Overview
  52. 6.9.3 Techwell Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Techwell Ovulation Induction Product Portfolio
  54. 6.9.5 Techwell Recent Developments
  55. 6.10 Sun Pharmaceutical
  56. 6.10.1 Sun Pharmaceutical Company Information
  57. 6.10.2 Sun Pharmaceutical Business Overview
  58. 6.10.3 Sun Pharmaceutical Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sun Pharmaceutical Ovulation Induction Product Portfolio
  60. 6.10.5 Sun Pharmaceutical Recent Developments
  61. 6.11 Pharmascience Inc
  62. 6.11.1 Pharmascience Inc Company Information
  63. 6.11.2 Pharmascience Inc Business Overview
  64. 6.11.3 Pharmascience Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Pharmascience Inc Ovulation Induction Product Portfolio
  66. 6.11.5 Pharmascience Inc Recent Developments
  67. 6.12 Par pharmaceutical inc
  68. 6.12.1 Par pharmaceutical inc Company Information
  69. 6.12.2 Par pharmaceutical inc Business Overview
  70. 6.12.3 Par pharmaceutical inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Par pharmaceutical inc Ovulation Induction Product Portfolio
  72. 6.12.5 Par pharmaceutical inc Recent Developments
  73. 6.13 Pacific Pharmaceuticals
  74. 6.13.1 Pacific Pharmaceuticals Company Information
  75. 6.13.2 Pacific Pharmaceuticals Business Overview
  76. 6.13.3 Pacific Pharmaceuticals Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Pacific Pharmaceuticals Ovulation Induction Product Portfolio
  78. 6.13.5 Pacific Pharmaceuticals Recent Developments
  79. 6.14 LIVZON
  80. 6.14.1 LIVZON Company Information
  81. 6.14.2 LIVZON Business Overview
  82. 6.14.3 LIVZON Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 LIVZON Ovulation Induction Product Portfolio
  84. 6.14.5 LIVZON Recent Developments
  85. 6.15 Ipsen
  86. 6.15.1 Ipsen Company Information
  87. 6.15.2 Ipsen Business Overview
  88. 6.15.3 Ipsen Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Ipsen Ovulation Induction Product Portfolio
  90. 6.15.5 Ipsen Recent Developments
  91. 6.16 IBSA
  92. 6.16.1 IBSA Company Information
  93. 6.16.2 IBSA Business Overview
  94. 6.16.3 IBSA Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 IBSA Ovulation Induction Product Portfolio
  96. 6.16.5 IBSA Recent Developments
  97. 6.17 IBM Micromedex
  98. 6.17.1 IBM Micromedex Company Information
  99. 6.17.2 IBM Micromedex Business Overview
  100. 6.17.3 IBM Micromedex Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 IBM Micromedex Ovulation Induction Product Portfolio
  102. 6.17.5 IBM Micromedex Recent Developments
  103. 6.18 Gedeon Richter
  104. 6.18.1 Gedeon Richter Company Information
  105. 6.18.2 Gedeon Richter Business Overview
  106. 6.18.3 Gedeon Richter Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Gedeon Richter Ovulation Induction Product Portfolio
  108. 6.18.5 Gedeon Richter Recent Developments
  109. 6.19 Fresenius Kabi
  110. 6.19.1 Fresenius Kabi Company Information
  111. 6.19.2 Fresenius Kabi Business Overview
  112. 6.19.3 Fresenius Kabi Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Fresenius Kabi Ovulation Induction Product Portfolio
  114. 6.19.5 Fresenius Kabi Recent Developments
  115. 6.20 Ferring
  116. 6.20.1 Ferring Company Information
  117. 6.20.2 Ferring Business Overview
  118. 6.20.3 Ferring Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Ferring Ovulation Induction Product Portfolio
  120. 6.20.5 Ferring Recent Developments
  121. 6.21 Endo
  122. 6.21.1 Endo Company Information
  123. 6.21.2 Endo Business Overview
  124. 6.21.3 Endo Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Endo Ovulation Induction Product Portfolio
  126. 6.21.5 Endo Recent Developments
  127. 6.22 EMD Serono Inc
  128. 6.22.1 EMD Serono Inc Company Information
  129. 6.22.2 EMD Serono Inc Business Overview
  130. 6.22.3 EMD Serono Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 EMD Serono Inc Ovulation Induction Product Portfolio
  132. 6.22.5 EMD Serono Inc Recent Developments
  133. 6.23 Emcure Pharmaceuticals Ltd.
  134. 6.23.1 Emcure Pharmaceuticals Ltd. Company Information
  135. 6.23.2 Emcure Pharmaceuticals Ltd. Business Overview
  136. 6.23.3 Emcure Pharmaceuticals Ltd. Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio
  138. 6.23.5 Emcure Pharmaceuticals Ltd. Recent Developments
  139. 6.24 Cosette Pharmaceuticals, Inc
  140. 6.24.1 Cosette Pharmaceuticals, Inc Company Information
  141. 6.24.2 Cosette Pharmaceuticals, Inc Business Overview
  142. 6.24.3 Cosette Pharmaceuticals, Inc Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio
  144. 6.24.5 Cosette Pharmaceuticals, Inc Recent Developments
  145. 6.25 Bristol Myers Squibb
  146. 6.25.1 Bristol Myers Squibb Company Information
  147. 6.25.2 Bristol Myers Squibb Business Overview
  148. 6.25.3 Bristol Myers Squibb Ovulation Induction Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Bristol Myers Squibb Ovulation Induction Product Portfolio
  150. 6.25.5 Bristol Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Ovulation Induction Market Size (2021-2032)
  2. 7.2 North America Ovulation Induction Market Size by Type
  3. 7.2.1 North America Ovulation Induction Market Size by Type (2021-2026)
  4. 7.2.2 North America Ovulation Induction Market Size by Type (2027-2032)
  5. 7.2.3 North America Ovulation Induction Market Share by Type (2021-2032)
  6. 7.3 North America Ovulation Induction Market Size by Application
  7. 7.3.1 North America Ovulation Induction Market Size by Application (2021-2026)
  8. 7.3.2 North America Ovulation Induction Market Size by Application (2027-2032)
  9. 7.3.3 North America Ovulation Induction Market Share by Application (2021-2032)
  10. 7.4 North America Ovulation Induction Market Size by Country
  11. 7.4.1 North America Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Ovulation Induction Market Size by Country (2021-2026)
  13. 7.4.3 North America Ovulation Induction Market Size by Country (2027-2032)
  14. 7.4.4 North America Ovulation Induction Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Ovulation Induction Market Size (2021-2032)
  2. 8.2 Europe Ovulation Induction Market Size by Type
  3. 8.2.1 Europe Ovulation Induction Market Size by Type (2021-2026)
  4. 8.2.2 Europe Ovulation Induction Market Size by Type (2027-2032)
  5. 8.2.3 Europe Ovulation Induction Market Share by Type (2021-2032)
  6. 8.3 Europe Ovulation Induction Market Size by Application
  7. 8.3.1 Europe Ovulation Induction Market Size by Application (2021-2026)
  8. 8.3.2 Europe Ovulation Induction Market Size by Application (2027-2032)
  9. 8.3.3 Europe Ovulation Induction Market Share by Application (2021-2032)
  10. 8.4 Europe Ovulation Induction Market Size by Country
  11. 8.4.1 Europe Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Ovulation Induction Market Size by Country (2021-2026)
  13. 8.4.3 Europe Ovulation Induction Market Size by Country (2027-2032)
  14. 8.4.4 Europe Ovulation Induction Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Ovulation Induction Market Size (2021-2032)
  2. 9.2 China Ovulation Induction Market Size by Type
  3. 9.2.1 China Ovulation Induction Market Size by Type (2021-2026)
  4. 9.2.2 China Ovulation Induction Market Size by Type (2027-2032)
  5. 9.2.3 China Ovulation Induction Market Share by Type (2021-2032)
  6. 9.3 China Ovulation Induction Market Size by Application
  7. 9.3.1 China Ovulation Induction Market Size by Application (2021-2026)
  8. 9.3.2 China Ovulation Induction Market Size by Application (2027-2032)
  9. 9.3.3 China Ovulation Induction Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Ovulation Induction Market Size (2021-2032)
  2. 10.2 Asia Ovulation Induction Market Size by Type
  3. 10.2.1 Asia Ovulation Induction Market Size by Type (2021-2026)
  4. 10.2.2 Asia Ovulation Induction Market Size by Type (2027-2032)
  5. 10.2.3 Asia Ovulation Induction Market Share by Type (2021-2032)
  6. 10.3 Asia Ovulation Induction Market Size by Application
  7. 10.3.1 Asia Ovulation Induction Market Size by Application (2021-2026)
  8. 10.3.2 Asia Ovulation Induction Market Size by Application (2027-2032)
  9. 10.3.3 Asia Ovulation Induction Market Share by Application (2021-2032)
  10. 10.4 Asia Ovulation Induction Market Size by Country
  11. 10.4.1 Asia Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Ovulation Induction Market Size by Country (2021-2026)
  13. 10.4.3 Asia Ovulation Induction Market Size by Country (2027-2032)
  14. 10.4.4 Asia Ovulation Induction Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Ovulation Induction Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Ovulation Induction Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Ovulation Induction Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Ovulation Induction Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Ovulation Induction Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Ovulation Induction Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Ovulation Induction Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Ovulation Induction Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Ovulation Induction Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Ovulation Induction Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Ovulation Induction Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Ovulation Induction Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Ovulation Induction Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Ovulation Induction Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst